Dr. Hongyan Lin | Pharmaceutical Chemistry | Best Researcher Award

Dr. Hongyan Lin | Pharmaceutical Chemistry | Best Researcher Award

Changzhou University | China

Dr. Hongyan Lin is a distinguished researcher and lecturer at the School of Pharmaceutical Sciences, Changzhou University, China, with a strong emphasis on natural product chemistry and molecular pharmacology. She completed her Bachelor’s degree in Bioengineering at Changzhou University, followed by an Integrated Master-PhD in Biology at Nanjing University, where she specialized in the biological mechanisms of traditional medicine. Dr. Lin further expanded her expertise as a Postdoctoral Fellow and Research Associate at the School of Life Sciences, Nanjing University, contributing significantly to molecular pharmacology and natural product research. Her research interests focus on the chemical structural modification of natural products for anticancer applications, the role of traditional Chinese medicine in regulating intestinal microbiota to prevent colitis-associated cancer, and the isolation, structural identification, and biological activity of bioactive compounds from traditional herbs. Dr. Lin has been recognized for her scientific contributions through research grants and academic publications in high-impact journals. Her work supports the evolution of natural product-based therapeutics and offers promising directions for cancer prevention and treatment. In her role as a lecturer and researcher, she continues to inspire the next generation of pharmaceutical scientists through her dedication and innovation.

Profiles: Scopus | Orcid

Featured Publications

Lin, H., Ai, D., Liu, Q., Wang, X., Gao, J., Chen, Q., Ruan, L., Tao, Y., Gao, J., & Wang, L. (2023). Modified Podophyllotoxin Phenoxyacetamide Phenylacetate Derivatives: Tubulin/AKT1 Dual-Targeting and Potential Anticancer Agents for Human NSCLC. Journal of Natural Products, Published online July 28, 2023.

Lin, H., Zhou, Z., Ma, X., Chen, Q., Han, H., Wang, X., Qi, J., & Yang, Y. (2021). One pot synthesis of aryl nitriles from aromatic aldehydes in a water environment. RSC Advances, 2021.

Prof. Jianli Liu | Chemical Toxicology | Best Researcher Award

Prof. Jianli Liu | Chemical Toxicology | Best Researcher Award

Liaoning University | China

Prof. Jianli Liu is a distinguished researcher and educator in the field of biotechnology and medical genetics, with a strong academic foundation spanning from a Bachelor’s and Master’s degree in Biotechnology at Shenyang Agricultural University to a Ph.D. in Medical Genetics from China Medical University, where his doctoral work focused on CDK2 expression regulated by STK15 in laryngeal carcinoma. He began his academic career as a tutor at Liaoning University, advancing through the roles of lecturer and associate professor, and currently serves as a professor at the Life Science School of Liaoning University. Prof. Liu’s research interests lie in molecular mechanisms of disease, cellular signaling pathways, and the protective effects of natural products such as polysaccharides, anthocyanins, and polyphenols against environmental stressors including high glucose and PM2.5-induced damage. He has led multiple nationally funded projects, including those supported by the National Natural Science Foundation of China and regional innovation programs, focusing on lung disease, β-cell protection, heavy metal pollution control, and therapeutic potentials of bioactive compounds. Recognized for his impactful contributions, Prof. Liu continues to advance interdisciplinary research bridging biotechnology, medicine, and environmental health, while inspiring future scientists through his teaching and mentorship.

Profile: Scopus

Featured Publications

Study on the causality of cathepsin on autoimmune diseases and cancer: evidence from mendelian randomization analysis

Cadmium induces the secretion of SASP factors regulated by MAPK and NF-κB signaling pathways in HEK293 cells: A possible mechanism of acute kidney damage induced by cadmium

Genetic Association of Chronic Pains and Analgesics With Telomere Length: A Mendelian Randomization Study

Cadmium exposure induces inflammation, oxidative stress and DNA damage in HUVEC and promotes THP-1 adhesion: A possible mechanism on the formation of atherosclerotic plaque

Assessments of Pollution Status and Human Health Risk of Potentially Toxic Elements in Primary Crops and Agricultural Soils in Guanajuato, Mexico

Association between cadmium exposure and the risk of cardiovascular outcomes: a meta-analysis

Ms. Yufang Ma-Pharmaceutical Chemistry-Best Researcher Award

Ms. Yufang Ma-Pharmaceutical Chemistry-Best Researcher Award

Wuhan University - China

Author Profile

Early Academic Pursuits

Ms. Yufang Ma's academic journey began with a fervent interest in the biomedical sciences. She completed her undergraduate studies with a focus on pharmacology, where she developed a strong foundation in understanding drug interactions and biological systems. Her early research interests centered around natural compounds, particularly flavonoids, which are known for their diverse pharmacological properties. This interest led her to delve deeper into the conformational relationships of these compounds, exploring how their structures influence their biological activities. Her dedication to her studies was reflected in her academic excellence and active participation in various research initiatives.

Professional Endeavors

Following her undergraduate studies, Ms. Yufang Ma pursued a Master's degree at Wuhan University, one of the top institutions in China. Her professional endeavors have been marked by her commitment to advancing pharmacological research. At Wuhan University, she has been primarily engaged in studying the conformational relationships of flavonoids and their pharmacological effects. Her research aims to uncover the therapeutic potential of these natural compounds, particularly in the context of treating neurological disorders such as epilepsy. This work not only contributes to the scientific community's understanding of flavonoids but also has the potential to lead to the development of new, effective treatments for epilepsy.

Contributions and Research Focus

Ms. Yufang Ma's contributions to pharmacological research are centered on her in-depth studies of flavonoids. Her primary research focus involves investigating the conformational relationships of these compounds and how their structural variations impact their pharmacological properties. She is particularly interested in the therapeutic potential of flavonoids in treating epilepsy, a neurological disorder characterized by recurrent seizures. Through her research, she aims to identify specific flavonoids that can modulate neuronal activity and reduce seizure frequency. This focus on epilepsy research is a significant contribution to the field, as it addresses a critical need for new, effective treatments for this debilitating condition.

Accolades and Recognition

While Yufang Ma's work is ongoing, she has already garnered recognition for her contributions to pharmacological research. Her dedication to exploring the therapeutic potential of flavonoids has been acknowledged by her peers and mentors at Wuhan University. Although she has not yet published extensively or secured patents, her research on epilepsy is paving the way for significant advancements in the field. The recognition she has received serves as a testament to her potential to make impactful contributions to pharmacology and therapeutics.

Impact and Influence

The impact of Yufang Ma's research extends beyond the academic community. Her work on flavonoids and epilepsy has the potential to influence the development of new pharmacological treatments. By identifying specific flavonoids with anticonvulsant properties, her research could lead to the creation of novel therapies that offer better efficacy and fewer side effects compared to existing treatments. This potential impact highlights the broader significance of her work in improving patient outcomes and enhancing the quality of life for individuals with epilepsy.

Legacy and Future Contributions

Ms. Yufang Ma's legacy in pharmacological research is still in the making, but her ongoing work promises to leave a lasting impact on the field. As she continues to explore the therapeutic potential of flavonoids, her findings could pave the way for new treatment paradigms in epilepsy and other neurological disorders. Her future contributions are likely to extend beyond research, potentially influencing clinical practices and drug development strategies. With her dedication and innovative approach, Ms. Yufang Ma is poised to become a leading figure in pharmacology, contributing to the advancement of science and the improvement of human health.

Notable Publication

Apigenin analogs as α-glucosidase inhibitors with antidiabetic activity, 2024.

Diosmetin Ameliorates HFD-induced Cognitive Impairments via Inhibiting Metabolic Disorders, Mitochondrial Dysfunction and Neuroinflammation in Male SD Rats, 2024